Catalyst Pharmaceuticals (CPRX) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 72.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.11% |
| Dec 31, 2025 | 33.45% |
| Sep 30, 2025 | 39.15% |
| Jun 30, 2025 | 45.73% |
| Mar 31, 2025 | 48.21% |
| Dec 31, 2024 | 44.53% |
| Sep 30, 2024 | 41.89% |
| Jun 30, 2024 | 40.56% |
| Mar 31, 2024 | 34.59% |
| Dec 31, 2023 | 1.86% |
| Sep 30, 2023 | 1.09% |
| Jun 30, 2023 | 15.83% |
| Mar 31, 2023 | 13.37% |
| Dec 31, 2022 | 49.38% |
| Sep 30, 2022 | 78.55% |
| Jun 30, 2022 | 108.06% |
| Mar 31, 2022 | 110.65% |
| Dec 31, 2021 | 117.95% |
| Sep 30, 2021 | 144.32% |
| Jun 30, 2021 | 139.18% |
| Mar 31, 2021 | 86.59% |
| Dec 31, 2020 | 31.33% |
| Sep 30, 2020 | 151.87% |
| Jun 30, 2020 | 137.54% |
| Mar 31, 2020 | 116.83% |
| Dec 31, 2019 | 86.08% |
| Sep 30, 2019 | 36.63% |
| Jun 30, 2019 | 7.75% |
| Mar 31, 2019 | -4.96% |
| Dec 31, 2018 | -16.30% |
| Sep 30, 2018 | -31.31% |
| Jun 30, 2018 | -35.72% |
| Mar 31, 2018 | -22.01% |
| Dec 31, 2017 | 84.89% |
| Sep 30, 2017 | -13.35% |
| Jun 30, 2017 | -16.61% |
| Mar 31, 2017 | 110.34% |
| Dec 31, 2016 | 84.39% |
| Sep 30, 2016 | 10.81% |
| Jun 30, 2016 | 177.16% |
| Mar 31, 2016 | 225.25% |
| Dec 31, 2015 | 171.56% |
| Sep 30, 2015 | 39.85% |
| Jun 30, 2015 | 70.46% |
| Mar 31, 2015 | 106.06% |
| Dec 31, 2014 | 14.70% |
| Sep 30, 2014 | 73.64% |
| Jun 30, 2014 | 63.19% |
| Mar 31, 2014 | -46.16% |
| Dec 31, 2013 | -26.03% |
| Sep 30, 2013 | 27.55% |